The prevalence, pathogenesis, predictors, and natural course of patients with recurrent
glomerulonephritis (GN) occurring after kidney transplantation remains incompletely …

Introduction: Despite major advances in kidney transplant, glucocorticoids (GCs) or steroids
remain one of the mainstay treatments. They possess adverse events (AEs) that are related …

Results Out of 504 transplant recipients with IgA nephropathy, recurrent IgA deposits were
identified by kidney biopsy in 82 patients; cumulative incidence of recurrence was 23% at 15 …

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide,
exhibiting a variable clinical and pathological course and significantly contributing to the …

IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. The
disease generally runs an indolent course but may lead to ESRD in 20–30% of patients in …

Abstract Background Recurrence of IgA nephropathy (IgAN) after kidney transplantation
occurs in about 30% of patients. The relevance of recurrence for the long-term graft survival …

Metabolic risk factors of cardiovascular disease such as abnormal glucose regulation,
obesity and metabolic syndrome, dyslipidaemia, metabolic bone disease, hyperuricaemia …

Primary IgA nephropathy (IgAN) is a common glomerular disorder defined by predominant
mesangial IgA deposition. Once thought to follow a progressive course in 10-20% of those …

IgA nephropathy (IgAN) represents a genetically complex multifactorial trait. Its prevalence
and clinical features vary geographically, and the disease has a range of clinical …

End-stage kidney disease (ESKD) is a main public health problem, the prevalence of which
is continuously increasing worldwide. Due to adverse effects of renal replacement therapies …